Vioxx Scorecard: 5-3-14192 Posted: August 7, 2006 As reported on CNNMoney.com, Merck won the most recent case in a Los Angeles state court on August 2, 2006, when a jury found that Vioxx did not cause the 2001 heart attack of plaintiff Stewart Grossberg, 71, a retired construction manager from Northridge, Calif. Many analysts are using the Vioxx win-loss scorecard as proof that Merck's strategy is "prudent" and paying off, which is all good for selling Merck stock, but do the numbers justify the rosy forecasts? I thought it would be fun to work with the numbers and make some predictions regarding how many more years of Vioxx litigation Merck has in store and how many man years of effort will be involved. Read more about this and check my math in today's post to Pharma Marketing Blog. For more posts in related topic areas, see: Companies Pain Drugs If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe. Enter your Email Address | Return to Pharma Marketing Blog Topics |

In what year will the last Vioxx trial be settled at the current rate? 2010 2016 2099 3340 3780 StarDate 44012.3